1 янв 2004 г. - FDA approves first "anti-angiogenic" drug, bevacizumab

Описание:

Bavacizumab is the first of a new generation of targeted drugs that attacked cancer by blocking blood flow to the tumors.

Добавлено на ленту времени:

16 ноя 2018

0

0

254

Cancer Dates

Дата: